Susanne Malander
Impact in
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
- Oncology top 5%
- PARP inhibition in cancer therapy
Papers in
-
- Ovarian cancer diagnosis and treatment 33
-
- Endometrial and Cervical Cancer Treatments 9
- Co-authors
- Mef NilbertAnna MåsbäckMona RidderheimIngrid HedenfalkUlf KristofferssonMansoor Raza MirzaBente LundBritta Halvarsson
- Journals
- Gynecologic Oncology (5 papers)Annals of Oncology (4 papers)International Journal of Gynecological Cancer (3 papers)Journal of Clinical Oncology (3 papers)Acta Oncologica (3 papers)
- Partner nations
- SwedenDenmarkUnited States
In The Last Decade
Susanne Malander
43 papers receiving 990 citations
Peers
Comparison fields: 5 of 69
- Reproductive Medicine 537
- Oncology 497
- Cancer Research 187
- Pathology and Forensic Medicine 207
- Obstetrics and Gynecology 89
Countries citing papers authored by Susanne Malander
This map shows the geographic impact of Susanne Malander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Malander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Malander more than expected).
Fields of papers citing papers by Susanne Malander
This network shows the impact of papers produced by Susanne Malander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Malander. The network helps show where Susanne Malander may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Susanne Malander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 3 | |
| 6 | 2020 | 7 | |
| 7 | 2020 | 6 | |
| 8 | 2019 | 187 | |
| 9 | 2018 | 87 | |
| 10 | 2017 | 7 | |
| 11 | 2017 | 8 | |
| 12 | 2015 | 33 | |
| 13 | 2014 | 29 | |
| 14 | 2014 | 13 | |
| 15 | ICON7: FINAL OVERALL SURVIVAL RESULTS IN THE GCIG PHASE III RANDOMISED TRIAL OF BEVACIZUMAB IN NEWLY DIAGNOSED OVARIAN CANCER | 2013 | 6 |
| 16 | 2005 | 29 | |
| 17 | 2005 | 95 | |
| 18 | 2003 | 71 | |
| 19 | 2001 | 11 | |
| 20 | 2000 | 10 |
About Susanne Malander
Susanne Malander is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 44 papers that have together received 1.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (33 papers), PARP inhibition in cancer therapy (10 papers), Endometrial and Cervical Cancer Treatments (9 papers), Genetic factors in colorectal cancer (7 papers), BRCA gene mutations in cancer (6 papers), Intraperitoneal and Appendiceal Malignancies (4 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Reproductive Medicine (537 citations), Oncology (497 citations), Cancer Research (187 citations), Pathology and Forensic Medicine (207 citations) and Obstetrics and Gynecology (89 citations). Susanne Malander has collaborated with scholars based in Sweden, Denmark and United States. Frequent co-authors include Mef Nilbert, Anna Måsbäck, Mona Ridderheim, Ingrid Hedenfalk, Ulf Kristoffersson, Mansoor Raza Mirza, Bente Lund, Britta Halvarsson, Päivi Kannisto and Eva Rambech. Their work appears in journals such as Gynecologic Oncology, Annals of Oncology, International Journal of Gynecological Cancer, Journal of Clinical Oncology and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.